Dr. Dror Wohlfeiler is a seasoned pharmaceutical professional with more than 30 years of experience gained working in the EU, US, Israel, Japan and other Asian countries, in site, regional and corporate roles.
Headed the Japan specialty and generic R&D project development at Teva from 2007 to 2017. Before 2007 acted as head of Quality Control for Teva’s operation division.
Built and managed teams in branded and generic R&D, supervised global project teams for Phase I - III drug developments resulting in more than 100 approved ANDA submissions, 2 NDA’s and numerous Phase 3 trials in Japan.
Used to work and live for 4 years in Japan started at t Kowa-Teva JV as the head of R&D and Board member. In this role, led a R&D organization that was based in 5 territories to successful product developments and ANDA approvals in Japan.